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The ﬂow of cortical information through the basal ganglia is a complex spatiotemporal
pattern of increased and decreased ﬁring. The striatum is the biggest input nucleus to
the basal ganglia and the aim of this study was to assess the role of inhibitory GABAA
and glycine receptors in regulating synaptic activity in the dorsolateral striatum (DLS) and
ventral striatum (nucleus accumbens, nAc). Local ﬁeld potential recordings from coronal
brain slices of juvenile and adultWistar rats showed that GABAA receptors and strychnine-
sensitive glycine receptors are tonically activated and inhibit excitatory input to the DLS
and to the nAc. Strychnine-induced disinhibition of glutamatergic transmission was insen-
sitive to the muscarinic receptor inhibitor scopolamine (10μM), inhibited by the nicotinic
acetylcholine receptor antagonist mecamylamine (10μM) and blocked by GABAA receptor
inhibitors, suggesting that tonically activated glycine receptors depress excitatory input to
the striatum through modulation of cholinergic and GABAergic neurotransmission. As an
end-product example of striatal GABAergic output in vivo we measured dopamine release
in the DLS and nAc by microdialysis in the awake and freely moving rat. Reversed dialysis of
bicuculline (50μM in perfusate) only increased extrasynaptic dopamine levels in the nAc,
while strychnine administered locally (200μM in perfusate) decreased dopamine output
by 60% in both the DLS and nAc. Our data suggest that GABAA and glycine receptors
are tonically activated and modulate striatal transmission in a partially subregion-speciﬁc
manner.
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INTRODUCTION
In addition to the control of movements, the basal ganglia are
involved in a variety of cognitive and mnemonic functions in
the generation and execution of context dependent behaviors
(Bolam et al., 2000). The striatum is the biggest input nucleus
to the basal ganglia and is innervated by excitatory cortical and
thalamic inputs that distribute in dorsomedial-to-ventromedial
zones (Nakano et al., 2000;Voorn et al., 2004), and by ﬁbers from
midbrain dopamine neurons that regulate reward and reward-
guidedlearning(Voornetal.,2004;Ikemoto,2007;Yinetal.,2008;
Ikemoto,2010). Striatal neurons discharge in response to ﬁring of
corticostriatal glutamatergic neurons,which leads to inhibition of
basal ganglia output neurons and disinhibition (direct) or inhibi-
tion (indirect) of neurons in the targets of the basal ganglia. The
output of the basal ganglia is thus a complex spatiotemporal pat-
ternof increasedanddecreasedﬁring,whichleadstoaninhibitory
outputsignalunderrestingconditionsthatisreducedduringbasal
ganglia associated behavior (Chevalier and Deniau, 1990).
Based on the subregion-speciﬁc extrinsic connections reach-
ing the striatum and observations from behavioral studies the
Abbreviations: EtOH, ethanol; nAc, nucleus accumbens; VTA, ventral tegmental
area.
striatal complex can be divided into the dorsal striatum (caudate–
putamen), which is necessary for the acquisition and expression
of instrumental actions,and the nucleus accumbens (nAc),which
has been attributed to be important for motivation, reward sen-
sation,and attention (Voorn et al.,2004;Yin and Knowlton,2004;
van Kuyck et al., 2007; Yin et al., 2008; Söderpalm et al., 2009).
However, reward-guided learning is not solely controlled by the
mesoaccumbens pathway arising from dopaminergic neurons in
the ventral tegmental area (VTA) and projecting to the nAc, but
alsoinvolvesthenigrostriatalpathway(Yinetal.,2008;Rushworth
et al.,2009).
Even though about 80% of the synapses in the striatum are
asymmetric glutamatergic synapses (Wilson, 2007), the major-
ity of neurons (>95%) are GABAergic medium spiny projection
neurons (MSNs; Tepper et al., 2004). MSNs form a weak lateral
inhibitory network among themselves via local axon collaterals
(feedback inhibition), while feedforward inhibition by GABAer-
gic interneurons appears to exert a more powerful control of
striatal excitability (Tepper et al., 2004). The striatum also con-
tains cholinergic interneurons, which have been implicated in
controlling both glutamatergic and GABAergic transmission onto
projecting MSNs (Zhou et al., 2002; Pakhotin and Bracci, 2007;
Sullivan et al., 2008). Furthermore, strychnine-sensitive glycine
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receptors expressed by cholinergic interneurons have been shown
tobeinvolvedinregulatingextracellularlevelsofacetylcholineand
dopamine(Yadidetal.,1993;Darsteinetal.,1997,2000;Molander
and Söderpalm, 2005a,b). Taken together, striatal output is bal-
anced by excitatory and inhibitory neurotransmission (Adermark
and Lovinger, 2009), which in turn adjust the ﬂow of cortical
information through the basal ganglia and regulate the activity
of midbrain dopamine neurons (Söderpalm et al.,2009; Ikemoto,
2010).Changesindopaminereleasecaninthiscontextberegarded
as an in vivo example of how an end-product is inﬂuenced by
synaptic output from the striatum.
TheaimofthisstudywastoassesstheroleofinhibitoryGABAA
and glycine receptors in regulating striatal neurotransmission.
Changes in excitatory input to the striatum were evaluated by
ﬁeld potential recordings conducted in the dorsolateral striatum
(DLS) and in the nAc core of acutely isolated brain slices from
juvenile and adult Wistar rats. Changes in dopamine output were
studied by in vivo microdialysis in awake and freely moving adult
Wistar rats.
MATERIALS AND METHODS
BRAIN SLICE PREPARATION
Experiments were carried out in accordance with the guidelines
laid down by the Swedish Council regarding the care and use of
animals for experimental procedures and were approved by the
Ethics Committee forAnimal Experiments,Gothenburg,Sweden.
Striatal brain slices were prepared from 20- to 23-day-old Wistar
rats (Breeding performed at Gothenburg University, rats origi-
nating from Charles River, Germany), or adult male Wistar rats
(270–350g; Taconic, Ejby, Denmark). Animals were deeply anes-
thetizedwithIsoﬂuraneBaxter(BaxtermedicalAB,Kista,Sweden)
and decapitated. The brains were quickly removed and placed in
ice-cold modiﬁed artiﬁcial cerebrospinal ﬂuid (aCSF) containing
(in mM); 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl2, 26 NaHCO3,
1.2 NaH2PO4, and 10 d-glucose, bubbled with a mixture of 95%
O2/5% CO2 gas. After a 5-min equilibration period,the brain tis-
sue was blocked at the anterior and posterior ends and attached
with histoacryl (Aesculap & Co., KG, Tuttlingen, Germany) to a
Teﬂon pad. The tissue was completely submerged into ice-cold
modiﬁedaCSFandsectionedcoronallyin400μmthicksliceswith
a vibrating tissues sectioning system (Campden Instruments Ltd.,
Loughborough,England). Brain slices were allowed to equilibrate
for at least 1h at room temperature in normal aCSF containing
(in mM); 124 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.2
NaH2PO4, and 10 d-glucose, continuously bubbled with a mix-
ture of 95% O2/5% CO2 gas before transferred to the recording
chamber.
STRIATAL FIELD POTENTIAL RECORDINGS
Fieldpotentialrecordingswereperformedaspreviouslydescribed
(Clarke and Adermark, 2010). In brief, one hemisphere of a slice
wastransferredtoarecordingchamberandperfusedataconstant
rate of 2.6ml/min with pre-warmed aCSF kept at 30˚C. Stimula-
tion was delivered as 0.1ms negative constant current pulses via a
monopolar tungsten electrode (World Precision Instruments, FL,
USA, type TM33B), activated at a frequency of 0.05Hz. Stimulus
intensity was set to yield an evoked PS amplitude approximately
half the size of the maximal evoked response. The half-maximal
responses ranged from 0.3 to 1.3mV in the DLS and 0.2 to 1.2
in the nAc, and were evoked with stimuli of 0.02–0.05mA in
intensity. For recordings in the DLS the stimulation electrode
was placed at the border of the subcortical white matter and
the striatum (Figure 1A). For recordings in the nAc core, the
stimulationelectrodewasplacedlocallyclosetotheanteriorcom-
missure dorsal to the recording electrode (Figure 1A). In a subset
of recordings PSs were evoked in the dorsomedial striatum. For
these recordings the stimulation electrode was placed inside the
striatum,as previously described byYin et al. (2007). After moni-
toring a stable baseline for 10min slices were treated with GABAA
receptor inhibitors (picrotoxin, 100μM; bicuculline, 2, 20μM),
glycine receptor inhibitors [strychnine, 0.1, 1μM, phenylbenzene
ω-phosphono-α-amino acid (PMBA), 50μM], or the nicotinic
acetylcholine receptor antagonist mecamylamine (10μM; Sigma
Aldrich, St Louis, MO, USA). Bicuculline was dissolved to 20mM
in DMSO and diluted to 2 or 20μM in aCSF.All other drugs were
dissolvedinaCSF.Signalswereampliﬁedbyacustommadeampli-
ﬁer, ﬁltered at 3kHz, digitized at 8kHz (12-bit Analog–Digital
converter with a maximum range of 10V) and transferred to a PC
for further analysis.
MICRODIALYSIS
Male Wistar rats (Taconic, Ejby, Denmark) weighing 270–350g
were housed four to a cage under controlled environmental con-
ditions(constantroomtemperatureof22˚C,humidityof65%,and
regularlight–darkconditionswithlightsonat07:00AMandoff at
07:00 PM). Animals had free access to tap water and standard rat
feed (Lantmännen, Kimstad, Sweden) and were allowed to adapt
tothenovelenvironmentforatleast1weekbeforeanyprocedures
were initiated. Only drug-naïve animals were used and all exper-
iments were performed during the light-phase of the cycle. The
experimental protocols were approved by the Ethics Committee
for Animal Experiments, Gothenburg, Sweden.
SURGERY AND EXPERIMENTAL PROCEDURE
Surgery was performed as previously described (Lidö et al.,2009).
In brief, rats were anesthetized with isoﬂurane, mounted onto a
stereotaxic instrument (David Kopf Instruments, Tujunga, CA,
USA), and put on a heating pad to prevent hypothermia during
the surgery. Three holes were drilled for the placement of anchor-
ing screws and an I-shaped dialysis probe (custom made in the
laboratory). The dialysis probes was lowered monolaterally into
either the DLS (A/P +1.2,M/L −3.4 relative to bregma,D/V −5.0
relative to the dura), or the nAc (A/P, +1.85; M/L, −1.4mm rel-
ative to bregma; and D/V, −7.8mm relative to dura), and placed
in the core–shell borderline region. The probe and the anchoring
screws were ﬁxed to the scull with Harvard cement (DAB Den-
tal AB, Stockholm, Sweden), and the rats were allowed to recover
for 2days before the dialysis experiments were initiated. On the
experimental day, the sealed inlet and outlet of the probes were
cut open and perfused with Ringer’s solution, consisting of (in
mM) 140 NaCl, 1.2 CaCl2, 3.0 KCl, and 1.0 MgCl2,a tar a t e
of 2μl/min for at least 1h to obtain a balanced ﬂuid exchange
before baseline sampling began. After a stable baseline had been
conﬁrmed drug administration was initiated. Separate groups of
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FIGURE1|E x citatory input to the striatum is inhibited by GABAergic
neurotransmission. (A) Schematic picture showing the location of
stimulating electrodes (black) and recording electrodes (gray) in the
dorsolateral striatum (DLS) and in the nAc core. (B,C)Treatment with 20μM,
but not 2μM, of the GABAA receptor antagonist bicuculline enhanced PS
amplitude in both the DLS and the nAc. (D) Example ﬁgure showing absolute
PS amplitude over time in the DLS and nAc during bicuculline-treatment. (E,F)
The increase in PS amplitude induced by 20μM bicuculline sustained in slices
from adult Wistar rats. (G)Treatment with the GABAA receptor blocker
picrotoxin (100μM) increased PS amplitude in the DLS, the dorsomedial
striatum (DMS), and in the nAc. Data show mean PS amplitudes compared to
baseline with SEM.
rats received either bicuculline (50, 100μM), or strychnine (20,
200μM). In a subset of experiments one additional probe was
implanted into the anterior VTA (A/P −5.2, M/L −0.7 relative to
bregma, D/V −8.4 relative to the dura). The nAChR antagonist
mecamylamine (100μM) was administered to theVTA in parallel
to bicuculline (50μM) perfusion in the nAc. By the end of the
experiment (−)-nicotine hydrogen tartrate salt dissolved in 0.9%
NaCl and neutralized with NaHCO3, was administered subcuta-
neouslyinavolumeof 2.0ml/kg.Thenicotinedoseisexpressedin
resultsectionasfreebase.Dialysatesamples(40μl)werecollected
every20min.Animalsweresacriﬁceddirectlyaftertheexperiment
and brains were placed in accustain (Sigma diagnostics, USA) for
3–7days before probe placements were veriﬁed using a vibroslicer
(Campden Instruments Ltd., Lafayette, IN, USA; Figure 5). Ani-
mals with inaccurate probe placements were excluded, as were
animals showing hemorrhaging due to probe insertion.
BIOCHEMICAL ASSAYS
Microdialysate dopamine content was separated and quantiﬁed
usinghighperformanceliquidchromatographywithelectrochem-
ical detection (HPLC-ED), as previously described in detail by
Lidö et al. (2009). In brief, a stainless steel ion exchange column
of 2mm×150mm, operated at 32˚C, and packed with Nucleosil
(5μM;SA 100A Phenomenex Scandinavia,Västra Frölunda,Swe-
den) was used. The mobile phase (ﬂow rate 0.3ml/min) consisted
of (in mM) 58 Citric acid,135 NaOH,0.107 Na2-EDTA,as well as
20% MeOH. The electrochemical detector (Decade, Kovalent AB,
Sweden) operated at 400mV vs. the cell (Hy-REF). An external
standardcontaining3.25fmol/μlofdopaminewasusedtoidentify
the dopamine peak, as well as quantify dopamine concentrations
inthedialysates.Allsampleswereanalyzedon-line.Theaverageof
thelasttwostablebaselinevalueswassetto100%foreachanimal.
DATA ANALYSIS
All graphs were assembled in GraphPad Prism (GraphPad Soft-
ware, Inc., San Diego, CA, USA), and Photoshop.
Field potential recordings; Data was analyzed with Clampex
10.1 (Molecular Devices,Foster City,CA,USA). Data is presented
intextasmeanPSamplitudecomparedtobaselinewith95%conﬁ-
denceinterval(CI)att =25–30minunlessanythingelseisclearly
stated. PSs were evoked every 20s and recorded amplitudes were
combined to give a mean value for each min. Time course ﬁgures
show mean PS amplitude compared to baseline for all recordings,
with SEM. Example traces are mean values calculated at baseline
and following 15–20min of drug treatment for one representative
recording. Two-tailed paired t-test was used for statistical analysis
unless anything else is stated.
Microdialysis; Two-way ANOVA with Bonferroni post-test to
compare replicate means by row was used for data analysis.
RESULTS
MODULATION OF EXCITATORY INPUT BY GABAA RECEPTOR
INHIBITORS
Treatment with a low concentration of the competitive GABAA
receptor antagonist bicuculline (2μM) did not signiﬁcantly
modulate PS amplitude in the DLS (PS amplitude=95±5%
of baseline, t =1.92, n =10, p >0.05), or nAc core (PS
amplitude=111±15% of baseline, t =1.50, n =13, p >0.05;
Figures 1B,C), while a higher concentration (20μM) enhanced
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PS amplitude in both DLS and nAc (Figures 1B,C). The rela-
tive increase was signiﬁcantly higher in the DLS as compared
to the nAc core (DLS: 141±16% of drug-free baseline; nAc:
119±12% of drug-free baseline; DLS vs. nAc, unpaired t-test,
t =2.08,df=21,p <0.05). The increase in PS amplitude induced
by 20μM bicuculline was sustained in slices from adult Wistar
rats (DLS: 149±16% of drug-free baseline; nAc: 122±14% of
drug-free baseline; DLS vs. nAc,unpaired t-test,t =2.55,df=24,
p <0.05; Figures 1E,F).
Treatmentwiththenon-competitiveGABAA receptorinhibitor
picrotoxin (100μM) also enhanced PS amplitude in the
DLS and in the nAc core (DLS: PS amplitude=141±9.3%
of drug-free baseline, t =8.37, n =15, p <0.001; nAc: PS
amplitude=118±9.4% of drug-free baseline, t =3.51, n =11,
p <0.01; Figure 1G). Picrotoxin also facilitated evoked PS in
thedorsomedialstriatum(PSamplitude=126±13%of baseline,
t =3.63,n =11,p <0.01; Figure 1G).
GLYCINE RECEPTORS IN THE STRIATUM ARE TONICALLY ACTIVATED
Treatmentwiththecompetitiveglycinereceptorantagoniststrych-
nine (0.1μM) induced a small, but signiﬁcant, increase in PS
amplitudeinthenAccore(113±8.7%of baseline,t =2.85,n =9,
p <0.05). A similar trend, although not signiﬁcant, was indi-
cated in the DLS (109±14% of baseline,t =1.25,n =9,p >0.05;
Figure 2A). Administration of a higher concentration (1μM)
signiﬁcantly enhanced PS amplitude in both the DLS and the
nAc core, suggesting that glycine receptors exhibit a tonic inhi-
bition in both subregions (DLS:114±9.5% of drug-free baseline,
t =2.81, n =10, p <0.05; nAc: PS amplitude=127±11% of
drug-free baseline, t =4.69, n =8, p <0.001; Figure 2B). The
increase in PS amplitude in the nAc remained over time and
was not reduced following 1h of strychnine-treatment (PS ampli-
tudeatt =60–65min=139±21%ofdrug-freebaseline,t =3.71,
n =6, p <0.05; Figure 2C). PS amplitude was not enhanced
further by a higher concentration of strychnine (10μM; DLS:
114±9.2% of drug-free baseline, t =3.01, n =10, p <0.05; nAc:
PSamplitude=126±11%of drug-freebaseline,t =4.66,n =11,
p <0.001; data not shown). Increased excitatory input follow-
ing strychnine administration was also conﬁrmed in slices from
adultWistarrats(DLS:111±9.2%of drug-freebaseline,t =2.40,
n =8, p <0.05; nAc: 125±9.8% of drug-free baseline, t =4.75,
n =9,p <0.01;Figures2D,E).PSamplitudewasalsoenhancedby
the non-competitive glycine receptor antagonist PMBA (50μM;
DLS: 130±14% of drug-free baseline, t =4.1, n =12, p <0.01;
nAc: 119±12% of drug-fee baseline, t =3.16, n =12, p <0.01;
Figure 2F).
DEACTIVATION OF GLYCINE RECEPTORS INCREASE THE EXCITATORY
INPUT TO THE STRIATUM THROUGH MODULATION OF CHOLINERGIC
AND GABAergic NEUROTRANSMISSION
Inhibitionof nicotinicacetylcholinereceptorsbythenon-selective
andnon-competitiveantagonistmecamylamineforatleast20min
before administration of 1μM strychnine signiﬁcantly depressed
the increase in PS amplitude induced by strychnine alone
(nAc: 112±2.8% of mecamylamine-treated baseline, strychnine
vs. strychnine+mecamylamine-treated slices, unpaired t-test,
FIGURE 2 | Glycine receptors are tonically activated and
depress excitatory input. (A) Inhibition of glycine receptors with
0.1μM strychnine induced a small increase in PS amplitude in the
nAc, and there was a trend for a similar effect in the DLS.
Example traces show evoked PSs at baseline (gray), and after 15–20min
exposure to 0.1μM strychnine (black) in the DLS. (B)Treatment with a higher
concentration of strychnine enhanced PS amplitude in both the DLS and in
the nAc. Example traces show evoked PSs at baseline (gray), and after
15–20min exposure to 1μM strychnine (black) in the DLS. (C)The enhancing
effect displayed by strychnine was not depressed over time. Example traces
show evoked PSs at baseline (gray), and after 50–55min exposure to 1μM
strychnine (black) in the nAc. (D,E) Strychnine enhanced PS amplitude to a
similar extent in slices from adult Wistar rats. (F) PS amplitudes in the DLS
and in the nAc were also enhanced by the glycine receptor antagonist PMBA
(50μM). Data show mean PS amplitudes compared to baseline with SEM.
Calibration: 0.2mV, 2ms.
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FIGURE 3 | Strychnine-induced enhancement of PS amplitude involves
nicotinic but not muscarinic acetylcholine receptors. (A)Treatment with
the nicotinic acetylcholine receptor inhibitor mecamylamine (10μM) did not
enhance PS amplitude in the DLS or in the nAc core. Example traces show
evoked population spikes in the DLS at baseline (gray) and after 15–20min of
mecamylamine-treatment (black). (B)The strychnine-induced enhancement of
PS amplitudes recorded in the nAc core remained in slices treated with the
muscarinic acetylcholine receptor antagonist scopolamine (10μM), but was
signiﬁcantly depressed in mecamylamine-treated slices. Example traces show
evoked population spikes at baseline (gray) and after 15–20min of strychnine
administration in a scopolamine-treated slice (black). Data show mean PS
amplitudes compared to baseline with SEM. Calibration: 0.2mV, 2ms.
t =2.53, df=30, p <0.05; Figure 3B). Treatment with the
non-selective muscarinic antagonist scopolamine (10μM) did
not modulate the strychnine-induced increase in PS ampli-
tude (128±12% of scopolamine-treated baseline,t =4.55,n =8,
p <0.01; Figure 3B). Baseline PS amplitude was not signiﬁ-
cantly modulated by mecamylamine (DLS: 105±4.8%, t =2.20,
n =11; nAc: 103±4.12%, t =1.62, n =13, p >0.05; Figure 3A)
orscopolamine(PSamplitude=102±6.8%ofdrug-freebaseline,
t =0.69,n =7,p >0.05; data not shown).
Pre-treatment with picrotoxin (100μM) inhibited the
strychnine-mediated increase in PS amplitude in both the DLS
(101±7.9% of picrotoxin-treated baseline, strychnine vs. strych-
nine+picrotoxin, df=21, t =2.11, p <0.05; Figure 4A), and in
the nAc core (PS amplitude=108±7.1% of picrotoxin-treated
baseline, strychnine vs. strychnine+picrotoxin, unpaired t-test,
t =2.77, df=14, p <0.01; Figure 4B). This result was fur-
ther supported by the ﬁnding that bicuculline (20μM) signiﬁ-
cantly depressed the strychnine-induced increase in PS amplitude
in the nAc (109±3.7% of bicuculline-treated baseline, strych-
ninevs.strychnine+bicuculline,unpairedt-test,t =3.0,df=14,
p <0.01; Figure 4B), and the PMBA-induced enhancement of PS
amplitudeintheDLS(103±7.2%of bicuculline-treatedbaseline,
PMBA vs. PMBA+bicuculline,unpaired t-test,t =3.12,df=21,
p <0.01;Figure4C). The strychnine-induced enhancement of PS
amplitude was also inhibited by a lower concentration of bicu-
culline (2μM), which by itself had no inﬂuence on PS amplitude
(see Figure 1; DLS: 101±3.2% of bicuculline-treated baseline,
t =0.30, n =8, p >0.05; nAc: 105±3.2% of bicuculline-treated
baseline, strychnine vs. bicuculline+strychnine, unpaired t-test,
t =3.12, df=17,p <0.01; Figure 4D).
MICRODIALYSIS
Local treatment with bicuculline (50μM) in the dorsal stria-
tum did not signiﬁcantly modulate dopamine release at any
speciﬁc time point (Time×drug interaction: F =1.64, p >0.05;
Drug: F =3.10, p >0.05; Figure 6A). A higher concentration
of bicuculline (100μM) in the same brain region enhanced the
microdialysate concentration of dopamine (Time×drug interac-
tion:F =19.20,p <0.001;Drug:F =32.38,p <0.001;Figure6A).
However, after 1h of drug treatment the animals started to
twitch with their heads toward the side to which bicuculline was
administered, and the experiments were instantly terminated.
In the nAc, administration of 50μM bicuculline was sufﬁ-
cient to induce a robust increase in dopamine concentration
(Time×drug interaction: F =16.87, p <0.001; Drug: F =18.38,
p <0.01; Figure 6B). Due to the adverse effects seen after admin-
istrationof 100μMbicucullineintheDLS,thisconcentrationwas
not administered in the nAc.
In a subset of experiments the nicotinic acetylcholine receptor
antagonistmecamylamine(100μM)wasadministeredintheVTA
for 40min before and continuously during bicuculline perfusion.
By the end of these experiments animals received a subcutaneous
injection of nicotine (0.4mg/kg). Mecamylamine did not prevent
thebicuculline-inducedincreaseindopamineoutput,butblocked
the nicotine-induced elevation of dopamine (Time×drug inter-
action: F <1.0,p >0.05; Drug: F <1.0,p >0.05; Figure 6C).
Treatment with the glycine receptor antagonist strychnine
(20μM) did not signiﬁcantly modulate the microdialysate con-
centration of dopamine in the DLS (Time×drug interaction:
F ≤1.0, p >0.05; p >0.05; Drug: F ≤1.0, p >0.05), or the nAc
(Time×drug interaction: F =1.616, p >0.05; p >0.05; Drug:
F ≤1.0, p >0.05; Figures 6D,E). However, administration of
a higher concentration of strychnine (200μM), signiﬁcantly
depressed the microdialysate concentration of dopamine in
both the DLS (Time×drug interaction: F =49.56, p <0.001;
p >0.05; Drug: F =44.14, p <0.001; Figure 6F), and in the nAc
(Time×drug interaction: F =18.42, p <0.05; Time: F =41.91,
p <0.001; Drug: F =32.05, p <0.001; Figure 6F).
DISCUSSION
GABAergic MODULATION OF EXCITATORY INPUT AND EXTRACELLULAR
DOPAMINE LEVELS
Synaptic transmission in the striatum is inhibited by two dis-
tinct GABAergic circuits; The feedforward circuit consisting of
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FIGURE 4 |Tonically activated glycine receptors depress excitatory
input to the striatum via GABAA receptors. (A,B)The strychnine-
induced enhancement of PS amplitude was signiﬁcantly depressed in
slices treated with the GABAA receptor blockers picrotoxin (100μM) or
bicuculline (20μM). Example traces show evoked population spikes at
baseline (gray) and after 15–20min of strychnine-treatment (black) in
a control slice (A) and in a bicuculline-treated slice (B). (C)The increase in PS
amplitude induced by the glycine receptor antagonist PMBA (50μM) was also
prevented in slices treated with bicuculline (20μM). Example traces show
evoked population spikes at baseline (black) and after 15–20min of
PMBA-treatment (gray). (D) Slices treated with a lower concentration of
bicuculline (2μM) also inhibited strychnine-induced enhancement of PS
amplitudes. Example traces show evoked population spikes in the nAc at
baseline (black) and after 15–20min of strychnine perfusion in a
bicuculline-treated slice (gray). Data show mean PS amplitudes compared to
baseline with SEM. Calibration: 0.2mV, 2ms.
GABAergic interneurons and the feedback circuit comprising of
MSNs (Tepper et al., 2004). Even though GABAergic interneu-
rons are outnumbered by MSNs, feedforward inhibition appears
to be more powerful with respect to the total number of synapses,
the synaptic strength, and the net effect on the postsynaptic
activity of the MSN (Tepper et al., 2008). Furthermore, intras-
triatal stimulation has previously been shown to preferentially
activateinhibitorysynapsesprovidedbyinterneurons(Tecuapetla
et al., 2005). Treatment with a high concentration of picrotoxin
(100μM) or bicuculline (20μM) enhanced PS amplitude by 40%
in the DLS showing that, even though the majority of synapses
are glutamatergic, GABAergic neurotransmission exerts a strong
inﬂuence on the excitatory input to the striatum (Wilson, 2007).
Inhibitionof GABAA receptorsalsoenhancedPSamplitudeinthe
nAc, but to a lesser extent, which might be related to differences
in GABAergic tone, receptor localization, or to the orientation
of dendritic arbors. Brain region speciﬁc localization of GABAA
receptors has previously been reported in other structures of the
basal ganglia. In the globus pallidus, GABAA receptors are exclu-
sivelypostsynaptic(Chararaetal.,2005),while,inthenAc,GABAA
receptors containing the alpha 1 subunit are localized on presy-
napticterminals(Churchilletal.,1991).Furthermore,intheVTA,
GABAA receptors appear to be localized on both dopaminergic
neurons and on GABAergic interneurons, resulting in both direct
inhibition and indirect disinhibition of dopamine release (Xi and
Stein, 1998).
The striatal nucleus is innervated by dopaminergic ﬁbers that
arise from the substantia nigra and the VTA (Voorn et al., 2004;
Ikemoto, 2007). Dopamine has previously been shown to play a
selectiveroleinthepresynapticmodulationof recurrentaxoncol-
laterals that interconnect spiny neurons (Guzmán et al., 2003),
but dopaminergic ﬁring in all parts of the striatum is also by
itself inﬂuenced by GABAergic neurotransmission (Santiago and
Westerink, 1992; Westerink et al., 1998; Tepper and Lee, 2007).
The data presented here shows that administration of bicuculline
enhances the microdialysate concentration of dopamine in both
thenAcandinthedorsalstriatum.Alowerconcentrationof bicu-
culline(50μM)onlyelevatedthemicrodialysateconcentrationof
dopamine in the nAc. The GABAergic inﬂuence on dopaminergic
output thus appears stronger in the nAc than in the DLS and is
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FIGURE 5 | Location of the microdialysis probes in the DLS and nAc.The black lines indicate the track of individual microdialysis probes in the DLS (A) and
the nAc (B). Distance from bregma (in mm) is shown to the right in each ﬁgure.
FIGURE 6 |The microdialysate concentration of dopamine
is regulated by GABAA and glycine receptors. (A)The
microdialysate concentration of dopamine was signiﬁcantly
enhanced by 100μM but not by 50μM bicuculline in the DLS.
(B) Bicuculline (50μM) applied by reversed microdialysis in the nAc
enhanced the extracellular level of dopamine. (C)The increase in dopamine
output induced by bicuculline administration in the nAc was not signiﬁcantly
modulated by mecamylamine co-perfused in the VTA. (D,E)The
microdialysate concentration of dopamine was not depressed by 20μM
strychnine in either brain region. (F) A higher concentration of strychnine
(200μM) signiﬁcantly depressed dopamine levels in both the DLS and in the
nAc.
probably largely unrelated to the GABAergic inﬂuence on excita-
tory input, as measured in the present set-up, which was stronger
in the DLS than in the nAc. This ﬁnding further points toward
a subregional distribution of GABAA receptors, but it should be
noted that GABAA receptor-mediated release of dopamine might
be further complicated by indirect and direct interactions in the
VTA and substantia nigra (Westerink et al., 1996).
Increased dopamine release in the nAc, as measured by micro-
dialysis, may after accumbal drug administration involve a nAc–
VTA–nAc neuronal circuitry employing nicotinic receptor activa-
tion in the VTA and subsequent activation of dopamine neurons
(Blomqvist et al., 1993, 1997; Söderpalm et al., 2009). In order
to evaluate if such a neurocircuitry was involved in bicuculline-
mediated dopamine release we administered mecamylamine in
the VTA in parallel to bicuculline perfusion in the nAc. The
bicuculline-induced increase in microdialysate concentration of
dopamine was not blocked by mecamylamine, suggesting that
GABAA receptor inhibition modulates dopamine release either
locally within the nAc or via a neurocircuitry different from the
nAc–VTA–nAc previously described. Importantly, the dopamine
elevating property of nicotine was prevented by mecamylamine
showing that nicotinic receptors in the VTA were indeed blocked
(Grenhoff et al., 1986).
In favor of the dopamine output being inﬂuenced by GABAer-
gic neurotransmission locally in the nAc, e.g., via interference
with presynaptic GABAA receptors on dopaminergic terminals,
may be the fact that such receptors previously have been impli-
cated in modulation of dopamine release (Aono et al., 2008).
However, another study performed in the striatum has sug-
gested that GABAA receptor antagonists primarily modulate
dopamine release postsynaptically via the striatonigral feedback
loop (Smolders et al., 1995). It is thus possible that the GABAA
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receptor is heterogeneously distributed within the basal ganglia,
and that these differences in localization enables it to contribute
differentially to various patterns of activity.
GLYCINERGIC MODULATION OF EXCITATORY INPUT AND
EXTRACELLULAR DOPAMINE LEVELS
Even though the expression of glycine receptors in the striatum
is relatively low (Malosio et al., 1991), they appear to be involved
inregulatingbasaldopaminelevelsandneurotransmission(Yadid
et al., 1993; Molander and Söderpalm, 2005b). Treatment with
strychnine enhanced PS amplitude in both the DLS and nAc sug-
gesting that glycine receptors are tonically activated and exert a
net inhibitory control of excitatory input. This ﬁnding was also
conﬁrmed in slices treated with PMBA, which has been reported
nottointeractwithα7nicotinicacetylcholine,NMDA,orGABAA
receptorswhenusedatconcentrationsbelow100μM(Saitohetal.,
1994; Renna et al.,2007). The glycine receptor can be activated by
glycine,taurine,and β-alanine,and microdialysate sampling from
thenAchasshownthatallthreeagonistsarepresentatmeasurable
levelsduringbaselineconditions(Lidöetal.,2009;Adermarketal.,
2011). This, in connection with the present data, indicates that
the glycine receptor is most likely endogenously activated during
baseline conditions. Furthermore, there was no signiﬁcant differ-
ence between data retrieved from juvenile rats and adult brain
slices,showing that there is no age related difference in glycinergic
tonicity when comparing slices from these two ages.
The immunoreactivity for glycine receptors in the striatum co-
localizes primarily with choline acetyl transferase (Darstein et al.,
1997), and activation of glycine receptors enhance strychnine-
sensitive acetylcholine release in vitro (Hernandes et al., 2007).
Since striatal cholinergic interneurons drive excitation of sur-
rounding GABAergic neurons (de Rover et al., 2002), activation
of cholinergic interneurons could be converted into widespread
recurrentinhibitionvianicotinicexcitationofGABAergicneurons
(Sullivan et al., 2008). Involvement of both nicotinic and GABAA
receptorsinstrychnine-mediatedenhancementofexcitatoryinput
was also supported by our data showing that the increase in PS
amplitude was inhibited by mecamylamine,picrotoxin,and bicu-
culline. This blockade was not connected to a ceiling effect caused
by disinhibition since a lower concentration of bicuculline,which
did not inﬂuence excitatory input, also blocked the strychnine-
induced enhancement of PS amplitude. However, the increase
in PS amplitude was only partially depressed by mecamylamine,
and it is thus possible that glycine receptors located elsewhere
could contribute to the net inhibition of excitatory input to the
striatum. For instance, glycine receptors could be expressed by
parvalbumin expressing GABAergic interneurons, and thus con-
trolstriatalactivitybymodulatingfeedforwardinhibition(Tepper
et al., 2004; Waldvogel et al., 2007). Furthermore, even though
glycine receptors have not been conﬁrmed to be expressed by
MSNs, the glycine receptor agonist taurine has been shown to
induce strychnine-sensitive chloride-mediated currents in these
neurons (Sergeeva and Haas,2001). Thus,glycine receptors might
alsobeexpressedbyGABAergicneurons,anddirectlyorindirectly
modulate striatal neurotransmission.
We have previously shown that activation of accumbal glycine
receptors with glycine, taurine, or β-alanine increases the micro-
dialysate concentration of dopamine in a strychnine-sensitive
manner (Molander and Söderpalm, 2005b; Ericson et al., 2006,
2010, 2011). Furthermore, previous data (Molander and Söder-
palm, 2005b) and the data presented here show that strychnine
depresses extracellular dopamine levels in both the nAc and
in the DLS. Interestingly, accumbal dopamine is enhanced by
glycine in vivo but not in slice recordings where the connection
between the striatum and dopaminergic cell bodies has been cut
off (MolanderandSöderpalm,2005b;Hernandesetal.,2007).The
dopamine-regulating impact displayed by glycine receptors in the
nActhusappearstoinvolveactivationof dopaminergiccellbodies
in the VTA. Whether the nigrostriatal feedback loop is involved
in regulating strychnine-mediated dopamine depression in the
DLS remains to be determined. Drug concentration in the micro-
dialysis experiments was increased compared to drug concentra-
tion used in the ﬁeld potential recordings since previous data has
shown that only a fraction of the drug administered diffuses out
of the microdialysis probe, even when small molecules such as
ethanol are perfused (Robinson et al., 2000).
In conclusion, the data presented here suggest that GABAA
receptors and glycine receptors in the striatum regulate excitatory
input to the dorsal and ventral striatum,and modulate extracellu-
lar dopamine levels in a partially subregion-speciﬁc manner.
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